IOPAMIRO 370 price in UAE

Overview

Welcome to Dwaey, specifically on IOPAMIRO 370 Injection/Solution for page.
This medicine contains an important and useful components, as it consists of Iopamidol.
IOPAMIRO 370 is available in the market in concentration 7.55g/10ml (equiv. to 370mg Iodine/ml) and in the form of Injection/Solution for.

BRACCO S.p.A. is the producer of IOPAMIRO 370 and it is imported from ITALY, The most popular alternatives of IOPAMIRO 370 are listed downward .

Mode Of Action

Iopamidol is a nonionic iodinated radiographic contrast medium. It allows visualisation of internal body structures by opacifying the path of its flow.

Indication

Radiographic contrast medium for diagnostic procedures

Precaution

May inhibit blood coagulation. Multiple myeloma or other paraproteinaemia. Sickle-cell disease. Known or suspected phaeochromocytoma (monitor closely). Hyperthyroidism. Ensure adequate hydration. History of a previous sensitivity to a contrast medium, sensitivity to iodine, bronchial asthma, hay fever and food allergy. Monitor patients with CHF. Avoid angiography in patients with homocystinuria. Severe arterial or venous disease. Severe renal impairment, combined renal and hepatic disease or anuria, especially when large doses are used. Pregnancy and lactation. Lactation: Excretion into breast milk unknown; not recommended

Side Effects

Arrhythmias
arterial spasm
flushing
vasodilatation
angina
cardiopulmonary arrest; dizziness
confusion
paraesthesia
visual disturbances
seizure
paralysis
coma
temporary amnesia; inj site pain
pallor
periorbital and facial oedema; coughing
sneezing
rhinitis
asthma
apnoea
laryngeal oedema
chest tightness; watery itchy eyes
lachrymation
conjunctivitis; muscle spasm
involuntary leg movement; tremors
malaise; severe retching and choking
abdominal pain; urogenital pain
haematuria. Potentially Fatal: Severe anaphylactoid reactions.

Contra indication

Not for intrathecal use.

Pregnancy and lactation

Pregnancy category: B

Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Interaction

Arrhythmias, arterial spasm, flushing, vasodilatation, angina, cardiopulmonary arrest; dizziness, confusion, paraesthesia, visual disturbances, seizure, paralysis, coma, temporary amnesia; inj site pain, pallor, periorbital and facial oedema; coughing, sneezing, rhinitis, asthma, apnoea, laryngeal oedema, chest tightness; watery itchy eyes, lachrymation, conjunctivitis; muscle spasm, involuntary leg movement; tremors, malaise; severe retching and choking, abdominal pain; urogenital pain, haematuria. Potentially Fatal: Severe anaphylactoid reactions.